Federated Hermes’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.95M | Sell |
45,639
-995,218
| -96% | -$54M | ﹤0.01% | 1019 |
|
|
2026
Q1 | $65.3M | Sell |
1,040,857
-636,029
| -38% | -$50.9M | 0.11% | 215 |
|
|
2025
Q4 | $160M | Buy |
1,676,886
+32,367
| +2% | +$3.17M | 0.27% | 93 |
|
|
2025
Q3 | $161M | Sell |
1,644,519
-168,986
| -9% | -$17.5M | 0.28% | 88 |
|
|
2025
Q2 | $195M | Buy |
1,813,505
+18,665
| +1% | +$1.89M | 0.37% | 65 |
|
|
2025
Q1 | $181M | Buy |
1,794,840
+95,950
| +6% | +$9.66M | 0.39% | 56 |
|
|
2024
Q4 | $152M | Buy |
1,698,890
+88,550
| +5% | +$7.8M | 0.33% | 71 |
|
|
2024
Q3 | $135M | Buy |
1,610,340
+529,111
| +49% | +$41.7M | 0.3% | 75 |
|
|
2024
Q2 | $83.3M | Buy |
1,081,229
+704,464
| +187% | +$51.6M | 0.2% | 124 |
|
|
2024
Q1 | $25.8M | Buy |
376,765
+194,895
| +107% | +$12.5M | 0.06% | 361 |
|
|
2023
Q4 | $10.5M | Sell |
181,870
-419
| -0.2% | -$22.4K | 0.03% | 549 |
|
|
2023
Q3 | $9.62M | Sell |
182,289
-1,415
| -0.8% | -$74.2K | 0.03% | 536 |
|
|
2023
Q2 | $9.94M | Buy |
183,704
+20,310
| +12% | +$1.06M | 0.02% | 540 |
|
|
2023
Q1 | $8.17M | Buy |
163,394
+47,341
| +41% | +$2.23M | 0.02% | 593 |
|
|
2022
Q4 | $5.37M | Sell |
116,053
-6,060
| -5% | -$262K | 0.01% | 672 |
|
|
2022
Q3 | $4.73M | Buy |
122,113
+230
| +0.2% | +$9.23K | 0.01% | 685 |
|
|
2022
Q2 | $4.54M | Sell |
121,883
-46,061
| -27% | -$1.87M | 0.01% | 710 |
|
|
2022
Q1 | $7.44M | Sell |
167,944
-26,755
| -14% | -$1.16M | 0.02% | 683 |
|
|
2021
Q4 | $8.27M | Buy |
194,699
+181,962
| +1,429% | +$7.65M | 0.02% | 702 |
|
|
2021
Q3 | $553K | Sell |
12,737
-708
| -5% | -$31.3K | ﹤0.01% | 1482 |
|
|
2021
Q2 | $575K | Buy |
13,445
+5,101
| +61% | +$215K | ﹤0.01% | 1477 |
|
|
2021
Q1 | $322K | Sell |
8,344
-917,208
| -99% | -$34.7M | ﹤0.01% | 1632 |
|
|
2020
Q4 | $33.3M | Sell |
925,552
-978,258
| -51% | -$35.3M | 0.07% | 335 |
|
|
2020
Q3 | $72.7M | Sell |
1,903,810
-198,944
| -9% | -$7.67M | 0.17% | 143 |
|
|
2020
Q2 | $73.8M | Sell |
2,102,754
-37,624
| -2% | -$1.35M | 0.18% | 130 |
|
|
2020
Q1 | $69.8M | Sell |
2,140,378
-99,042
| -4% | -$3.87M | 0.21% | 110 |
|
|
2019
Q4 | $101M | Sell |
2,239,420
-326
| -0% | -$13.6K | 0.23% | 96 |
|
|
2019
Q3 | $91.1M | Buy |
2,239,746
+668
| +0% | +$28.3K | 0.22% | 101 |
|
|
2019
Q2 | $96.2M | Sell |
2,239,078
-470,122
| -17% | -$18.1M | 0.23% | 96 |
|
|
2019
Q1 | $104M | Sell |
2,709,200
-80,669
| -3% | -$3.08M | 0.26% | 79 |
|
|
2018
Q4 | $98.6M | Sell |
2,789,869
-177,265
| -6% | -$6.43M | 0.27% | 79 |
|
|
2018
Q3 | $114M | Sell |
2,967,134
-236,804
| -7% | -$8.27M | 0.27% | 78 |
|
|
2018
Q2 | $105M | Sell |
3,203,938
-73,181
| -2% | -$2.21M | 0.31% | 75 |
|
|
2018
Q1 | $89.5M | Buy |
3,277,119
+372,435
| +13% | +$10.1M | 0.26% | 81 |
|
|
2017
Q4 | $72M | Buy |
2,904,684
+6,894
| +0.2% | +$190K | 0.2% | 99 |
|
|
2017
Q3 | $84.5M | Sell |
2,897,790
-7,027
| -0.2% | -$194K | 0.24% | 82 |
|
|
2017
Q2 | $80.5M | Sell |
2,904,817
-142,867
| -5% | -$3.79M | 0.23% | 83 |
|
|
2017
Q1 | $75.8M | Buy |
3,047,684
+364,426
| +14% | +$8.86M | 0.22% | 86 |
|
|
2016
Q4 | $58M | Buy |
2,683,258
+305,992
| +13% | +$6.68M | 0.17% | 114 |
|
|
2016
Q3 | $56.6M | Buy |
2,377,266
+2,344,021
| +7,051% | +$55.9M | 0.16% | 113 |
|
|
2016
Q2 | $777K | Buy |
33,245
+11,260
| +51% | +$244K | ﹤0.01% | 1163 |
|
|
2016
Q1 | $414K | Sell |
21,985
-12,503
| -36% | -$220K | ﹤0.01% | 1327 |
|
|
2015
Q4 | $636K | Sell |
34,488
-41,954
| -55% | -$752K | ﹤0.01% | 1222 |
|
|
2015
Q3 | $1.25M | Sell |
76,442
-1,719
| -2% | -$29.4K | ﹤0.01% | 1029 |
|
|
2015
Q2 | $1.38M | Sell |
78,161
-4,611
| -6% | -$82.4K | ﹤0.01% | 1049 |
|
|
2015
Q1 | $1.47M | Sell |
82,772
-214,594
| -72% | -$3.39M | ﹤0.01% | 1055 |
|
|
2014
Q4 | $3.94M | Buy |
297,366
+94,075
| +46% | +$1.2M | 0.01% | 703 |
|
|
2014
Q3 | $2.4M | Buy |
203,291
+86,993
| +75% | +$1.1M | 0.01% | 895 |
|
|
2014
Q2 | $1.49M | Buy |
116,298
+71,114
| +157% | +$925K | ﹤0.01% | 1054 |
|
|
2014
Q1 | $611K | Sell |
45,184
-7,372
| -14% | -$96.8K | ﹤0.01% | 1290 |
|
|
2013
Q4 | $631K | Buy |
52,556
+7,667
| +17% | +$90.6K | ﹤0.01% | 1270 |
|
|
2013
Q3 | $527K | Buy |
44,889
+1,628
| +4% | +$17.6K | ﹤0.01% | 1288 |
|
|
2013
Q2 | $401K | Buy |
+43,261
| New | +$367K | ﹤0.01% | 1339 |
|
Other funds holding BSX
Federated Hermes's BSX Position: Q2 2026 in Review
Federated Hermes reduced its Boston Scientific (BSX) stake by 96% in Q2 2026, selling an estimated $54M and leaving 45,639 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1019.
Federated Hermes first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $195M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Federated Hermes held 45,639 shares of Boston Scientific worth $1.95M as of Q2 2026.
- Federated Hermes sold 995,218 Boston Scientific shares in Q2 2026, an estimated $54M.
- Boston Scientific made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1019 holding.
- Federated Hermes first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Boston Scientific position peaked at $195M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.